Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor ...
We recently compiled a list of the BofA’s List Of AI & Semiconductor Stocks That Fund Managers Love & Hate: 16 Stocks On The ...
Hosted on MSN8d
Here's What to Expect From Synopsys' Next Earnings ReportSynopsys, Inc. (SNPS), based in California, is a renowned provider of electronic design automation (EDA) software for the ...
On Tuesday, Synopsys Inc (SNPS) stock saw a modest uptick, ending the day at $529.21 which represents a slight increase of $33.03 or 6.66% from the prior close of $496.18. The stock opened at $511 and ...
It’s no secret that Medicare Advantage payers are facing multiple market pressures: rising costs, higher utilization and the CMS payment model changes that HealthLeaders recently analyzed. Amidst ...
Ballentine Partners LLC lessened its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 12.8% during the 3rd ...
Key Insights Synopsys' estimated fair value is US$436 based on 2 Stage Free Cash Flow to Equity Synopsys' US$502 ...
Navigating health care: How those with chronic conditions and disabilities can find tailored support
Dual-eligible individuals -- those who qualify for both Medicare and Medicaid -- often face complex health needs and barriers ...
Allspring Global Investments Holdings LLC cut its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 24.0% ...
Below is Validea's guru fundamental report for SYNOPSYS INC (SNPS). Of the 22 guru strategies we follow, SNPS rates highest using our P/B Growth Investor model based on the published strategy of ...
Central Health Medicare Plan offers $0 premiums and low out-of-pocket caps in California, but its star ratings are poor.
The replay will be available until Synopsys announces its first quarter fiscal year 2025 results in February 2025. About ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback